BioVoice News April 2017 Issue 11 Volume 1 | Page 37

progression to Acquired Immunodeficiency Syndrome (AIDS). For example, a 32 base-pair deletion in CCR5 (see Figure 1) protects the host from being infected even if exposed to HIV-1. Among European Caucasians, the proportion of individuals each with two copies of the deletion is only about 0.1%. Even those with one copy of the deletion get some protection in terms of lower viral load; the proportion of such individuals is about 17%. In India, the deletion allele is absent in most ethnic groups (Majumder PP and Dey B: European Jour Hum Genet 9: 794; 2001), Chemokines are natural ligands for receptors that HIV-1 uses to enter the cells; these chemokine s compete with the virus for co-receptor binding and influence susceptibility to HIV-1. Several polymorphisms located in (1) regulatory regions of CCL5 (encoding CC-chemokine RANTES), and (2) coding and non- coding regions of MIP1α have been associated with both resistance to HIV-1 infection and progression. Polymorphisms resulting in increased expression of chemokines notably reduce the risk of acquiring HIV-1. Even though, numerous host factors that support HIV-1 replication have been identified using large scale siRNA (small interfering RNA) screens, genetic variants of only tumor susceptibility gene 101 (TSG101: -183T>C and +181A>C) and peptidyl propyl isomerase A (PPLA) genes were confirmed to modulate HIV pathogenesis. In parallel to expression of HIV-1 supporting factors, human genome encodes molecules that are intrinsic inhibitors of HIV-1 replication: most notably TRIM5α and APOBEC3G. Of these, common variants of TRIM5α suggest that it has no or only modest influence on HIV-1 disease outcome. An H186R coding change in APOBEC3G is reported to be associated with accelerated progression to AIDS in African population; thorough analysis in Caucasians did not show any association with HIV-1 control. Human genes critical to immunity or inflammation also play role in HIV-1 pathogenesis and have been of interest for genetic studies. Polymorphisms in the genes encoding cytokines, cytokine receptors have been associated with both resistance and disease progression. In this regard, variants in genes responsible for innate immunity to HIV-1 such as: (i) β-defensin 1 gene (DEFB1) are associated with higher level of HIV-1 RNA in breast milk, and (ii) mannose- binding lectin 2 protein (encoded by MBL2) with increased susceptibility to HIV-1 infection and/or accelerated disease progression, iii) polymorphisms in TLR-7 and -9 influence disease progression. Since the identification of CCR5-^32, an allele of CCR5 with a 32 bp deletion responsible for resistance to R5-virus acquisition, human genetics has undergone massive transitions BIOVOICENEWS.COM 37